LAURENTIU DUMITRESCU: Open Payments
NPI 1033421573 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 6 payments from 3 companies in 2025. Trend: 2023 $249 · 2024 $249 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $165 |
| Janssen Pharmaceuticals, Inc | 3 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $42 |
Products named: INGREZZA, INVEGA SUSTENNA, UZEDY.
Industry payments across CA — which companies pay providers there.
